YugM is typically expressed in Escherichia coli due to its scalability and cost efficiency. Key production parameters include:
Vector: Plasmid-based systems with inducible promoters (e.g., T7/lac).
Purification: Immobilized metal affinity chromatography (IMAC) leveraging the His tag .
Yield: ~0.1–1.0 mg/mL after reconstitution, with >85% purity (SDS-PAGE verified) .
YugM is primarily used in:
Antigen Production: Generating antibodies for microbial proteomics studies .
Structural Biology: Preliminary crystallization trials due to its small size and solubility .
Functional Annotation: Comparative studies to elucidate roles in B. subtilis colony architecture or stress response .
While YugM itself has not been studied extensively, recent advances in B. subtilis recombinant protein production inform its potential optimization:
Low Solubility: Membrane-associated proteins like YugM may require fusion tags or chaperones for proper folding .
Scalability: Batch-to-batch variability in E. coli systems affects industrial adoption .
KEGG: bsu:BSU31340
STRING: 224308.Bsubs1_010100017036
YugM is classified as an uncharacterized hypothetical protein in Bacillus subtilis . As with many y-genes in B. subtilis, its precise function remains to be elucidated through targeted experimental approaches. The protein can be recombinantly expressed with affinity tags such as His-tag to facilitate purification and subsequent functional characterization studies . Standard expression systems for this protein include E. coli and yeast platforms, which allow for the production of sufficient quantities for biochemical and structural analyses .
Recombinant YugM protein production typically employs either E. coli or yeast expression systems . When expressed with a His-tag, the protein can be purified to >80% purity using standard affinity chromatography methods as verified by SDS-PAGE analysis . The resulting protein is typically provided in PBS buffer for short-term storage at 4°C, or at -20°C to -80°C for long-term storage . Researchers should note that recombinant preparations contain <1.0 EU per μg of endotoxin as determined by the LAL method, making them suitable for various experimental applications .
While specific information about yugM's genetic context is limited in the provided search results, research on similar uncharacterized genes (y-genes) in B. subtilis demonstrates they often participate in genetic interaction networks with characterized genes. For example, other uncharacterized genes like ypmB, yerH, and yabM have been shown to have positive genetic interactions with mbl, a paralog of the essential cell shape determinant mreB . This pattern suggests that uncharacterized genes like yugM may similarly have specific functional relationships with characterized genes that can be revealed through genetic interaction studies.
A multifaceted approach is recommended for the functional characterization of YugM:
Genetic interaction studies: Implementing comprehensive double-mutant analysis, similar to methods used for other y-genes, to identify functional relationships. This involves creating gene knockouts or knockdowns using techniques like CRISPR-Cas9 with sgRNAs (fully complementary for full knockdown or mismatched for partial knockdown) .
Protein-protein interaction assays: Employing techniques such as co-immunoprecipitation, yeast two-hybrid assays, or proximity labeling to identify interaction partners.
Structural analysis: Using X-ray crystallography, NMR spectroscopy, or cryo-EM to determine the three-dimensional structure, potentially revealing functional domains.
Expression profiling: Analyzing gene expression patterns under various conditions to identify regulatory patterns and potential functional contexts.
Comparative genomics: Examining conservation and evolutionary relationships to gain insights into potential functions.
When designing genetic interaction (GI) experiments for YugM characterization, researchers should follow these methodological guidelines:
Systematic double-mutant creation: Generate combinations of yugM deletion/knockdown with other genes, prioritizing those in potentially related pathways.
Phenotypic analysis: Employ quantitative growth measurements to identify synthetic lethal, negative, or positive genetic interactions.
Control selection: Include appropriate controls such as known interacting gene pairs (e.g., bcrC and uppP which exhibit synthetic lethality ).
Knockdown calibration: Consider both full knockdowns using fully complementary sgRNAs and partial knockdowns using mismatched sgRNAs to capture a range of interaction strengths .
Environmental variation: Test interactions under multiple growth conditions to identify condition-specific functional relationships.
A scoring system should be implemented to quantify interaction strength, similar to approaches used in comprehensive B. subtilis genetic interaction studies .
The selection of an expression system for YugM biochemical characterization should be guided by the specific experimental objectives:
| Expression System | Advantages | Limitations | Recommended Applications |
|---|---|---|---|
| E. coli | High yield, rapid growth, well-established protocols | Potential folding issues with B. subtilis proteins, lack of specific post-translational modifications | Initial biochemical characterization, structural studies requiring high protein quantities |
| Yeast | Eukaryotic post-translational modifications, good for proteins toxic to bacteria | Lower yield than E. coli, longer expression time | Studies requiring specific modifications or when bacterial expression is problematic |
| Native B. subtilis | Authentic processing and folding, natural post-translational modifications | Lower yield, more complex purification | Functional studies requiring native-like protein state |
For most initial biochemical characterizations, E. coli expression with a His-tag appears to be the standard approach for YugM , providing sufficient purity (>80%) for preliminary studies.
Investigating genetic interactions between yugM and other uncharacterized genes requires a systematic approach:
Targeted double-mutant library construction: Generate a matrix of double mutants combining yugM with other uncharacterized genes, particularly focusing on y-genes that have shown interaction patterns in previous studies.
High-throughput phenotyping: Implement automated growth curve analysis to quantify fitness effects across multiple conditions.
Interaction network mapping: Construct a network visualization of interactions to identify patterns and clusters of functionally related genes.
Transcriptomic profiling of double mutants: Analyze expression changes in double mutants compared to single mutants to identify compensatory mechanisms.
Clustering analysis: Group genes based on similarity of genetic interaction profiles to predict functional relationships.
This approach has been productive for other uncharacterized genes in B. subtilis, revealing functional connections. For example, similar studies have identified that certain uncharacterized genes (ypmB, yerH, and yabM) interact specifically with mbl but not with its paralog mreB, suggesting specialized functional roles .
When facing contradictory data in YugM functional studies, researchers should implement the following resolution framework:
Experimental context analysis: Systematically examine differences in experimental conditions (media, growth phase, strain background) that might explain divergent results.
Technical validation: Use orthogonal techniques to verify key findings and eliminate method-specific artifacts.
Genetic background effects: Test for suppressor mutations or genetic modifiers by whole-genome sequencing of experimental strains.
Conditional functionality testing: Assess protein function across a range of environmental conditions, as some proteins display context-dependent functionality.
Concentration-dependent effects: Examine whether contradictory results might stem from different protein expression levels, potentially revealing concentration-dependent functionality.
Post-translational modification analysis: Investigate whether differences in post-translational modifications between expression systems explain functional discrepancies.
This systematic approach helps distinguish genuine biological complexity from experimental artifacts.
Distinguishing direct from indirect interactions requires multiple complementary approaches:
The integration of these approaches provides strong evidence for distinguishing direct functional relationships from broader network effects.
Quality control for recombinant YugM preparations should include these critical parameters:
These parameters should be verified before using recombinant YugM in functional studies to ensure reproducible and reliable results.
Based on standard practices for similar recombinant proteins, YugM stability can be maintained under the following conditions:
Short-term storage: Store at 4°C in PBS buffer for periods up to 1-2 weeks .
Long-term storage: Store at -20°C to -80°C, preferably in small aliquots to avoid repeated freeze-thaw cycles .
Buffer optimization: While PBS is the standard buffer , stability may be enhanced by adding glycerol (10-20%) or reducing agents like DTT (1 mM) if the protein contains cysteine residues.
Lyophilization option: For extended storage, lyophilized powder format may provide greater stability , with reconstitution immediately before use.
Freeze-thaw minimization: Prepare single-use aliquots to avoid protein degradation from repeated temperature cycling.
Activity monitoring: Implement periodic quality checks using a consistent functional assay to verify retained activity during storage.
Researchers should validate these conditions specifically for YugM through stability testing if long-term studies are planned.
When encountering challenges with YugM expression and purification, researchers should systematically address issues through this troubleshooting framework:
Low expression yield:
Optimize codon usage for the expression host
Test multiple expression strains (BL21(DE3), Rosetta, etc.)
Vary induction conditions (temperature, inducer concentration, induction time)
Consider using a stronger promoter or increasing copy number
Poor solubility:
Reduce expression temperature (16-20°C)
Co-express with chaperones
Test different solubility tags (MBP, SUMO, TrxA)
Optimize lysis buffer components (salt concentration, detergents, additives)
Degradation during purification:
Add protease inhibitors during all steps
Reduce processing time and temperature
Test N-terminal vs. C-terminal tag placement
Consider removing flexible regions identified by sequence analysis
Low purity after affinity chromatography:
Increase washing stringency
Add a second purification step (ion exchange, size exclusion)
Consider on-column refolding if inclusion bodies form
Test alternative tag systems if His-tag performance is suboptimal
Loss of activity:
Determine if the tag affects function and remove if necessary
Identify and maintain essential cofactors or metal ions
Optimize buffer conditions for stability (pH, salt, additives)
Each step should be systematically tested and documented to develop an optimized protocol specific to YugM.
Several cutting-edge technologies hold promise for accelerating YugM characterization:
AlphaFold2 and similar AI structure prediction tools: These can provide high-confidence structural models without crystallization, offering insights into potential functional domains and interaction surfaces.
CRISPR interference (CRISPRi) with titratible systems: Enables precise control of expression levels to study dosage-dependent phenotypes and genetic interactions.
Single-cell transcriptomics: Allows examination of cell-to-cell variation in response to YugM perturbation, potentially revealing subpopulation-specific functions.
High-throughput phenotyping platforms: Automated systems can test thousands of growth conditions to identify specific conditions where YugM function becomes apparent.
Cryo-electron tomography: Provides structural context within the native cellular environment to understand spatial organization and interactions.
Protein-protein interaction mapping using proximity labeling: Techniques like TurboID provide in vivo interaction landscapes with temporal resolution.
Metaproteomics approaches: Can reveal conservation of function across bacterial species by comparing interaction networks of homologs.
Integration of these technologies with traditional approaches will likely provide the most comprehensive understanding of YugM function.
Integration of yugM research into the broader B. subtilis systems biology landscape requires:
Network contextualization: Position yugM within established cellular networks (metabolic, transcriptional, protein-protein) using interaction data.
Multi-omics integration: Combine transcriptomic, proteomic, and metabolomic data from yugM mutants to identify affected pathways.
Condition-specific analysis: Test yugM function across diverse environmental conditions to identify condition-specific roles.
Synthetic genetic array analysis: Perform comprehensive genetic interaction screening similar to those conducted for other y-genes in B. subtilis .
Mathematical modeling: Incorporate yugM data into existing B. subtilis mathematical models to predict system-wide effects of perturbation.
Phylogenetic profiling: Compare yugM conservation patterns with those of functionally characterized genes to predict functional associations.
Growth phenotype analysis: Connect yugM to cellular fitness under various conditions through quantitative growth measurements.
This integrative approach contextualizes individual gene studies within the broader cellular framework, enhancing the significance of findings.
Several critical questions remain to be addressed regarding YugM function:
Evolutionary conservation and specialization: How conserved is yugM across Bacillus species and what does its phylogenetic distribution suggest about its function?
Condition-specific essentiality: Are there specific environmental conditions under which yugM becomes essential for B. subtilis survival?
Genetic interaction landscape: Does yugM exhibit specific patterns of genetic interactions similar to those observed for other uncharacterized genes like ypmB, yerH, and yabM that interact with mbl ?
Protein interactome: What proteins directly interact with YugM and what cellular processes do these interactions affect?
Structural determinants of function: What structural features of YugM determine its functionality, and how do they compare to proteins of known function?
Regulatory context: What transcriptional or post-translational mechanisms regulate YugM expression and activity?
Subcellular localization: Where is YugM localized within the B. subtilis cell and does this localization change under different conditions?
Potential redundancy: Are there other proteins with redundant functions that mask phenotypes in yugM mutants?
Addressing these questions will significantly advance our understanding of this uncharacterized protein and potentially reveal new aspects of B. subtilis biology.